메뉴 건너뛰기
New England Journal of Medicine
Volumn 362, Issue 12, 2010, Pages 1140-1142
Gut flora and hepatic encephalopathy in patients with cirrhosis
Author keywords

[No Author keywords available]
Indexed keywords

AMMONIA; ANTIBIOTIC AGENT; DISACCHARIDE; LACTULOSE; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; RIFAXIMIN;
EID: 77950240574     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1000850     Document Type: Editorial
Times cited : (69)
References (10)
  • 1
    • 0030879021 scopus 로고    scopus 로고
    • Treatment of hepatic encephalopathy
    • Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Engl J Med 1997;337:473-479
    • (1997) N Engl J Med , vol.337 , pp. 473-479
    • Riordan, S.M.1    Williams, R.2
  • 2
    • 69249166158 scopus 로고    scopus 로고
    • Secondary prophylaxis of hepatic encephalopathy: An open-label randomized controlled trial of lactulose versus placebo
    • Sharma BC, Sharma P, Agrawal A, Sarin SK. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo. Gastroenterology 2009;137:885-891
    • (2009) Gastroenterology , vol.137 , pp. 885-891
    • Sharma, B.C.1    Sharma, P.2    Agrawal, A.3    Sarin, S.K.4
  • 3
    • 33846446011 scopus 로고    scopus 로고
    • The burden of hepatic encephalopathy
    • Poordad FF. The burden of hepatic encephalopathy. Aliment Pharmacol Ther 2007;25:Suppl 1:3-9.
    • (2007) Aliment Pharmacol Ther , vol.25 , Issue.SUPPL. 1 , pp. 3-9
    • Poordad, F.F.1
  • 4
    • 0033034892 scopus 로고    scopus 로고
    • Prognostic significance of hepatic encephalopathy in patients with cirrhosis
    • Bustamante J, Rimola A, Ventura PJ, et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999;30:890-895
    • (1999) J Hepatol , vol.30 , pp. 890-895
    • Bustamante, J.1    Rimola, A.2    Ventura, P.J.3
  • 5
    • 0034944406 scopus 로고    scopus 로고
    • Hepatic encephalopathy
    • Practice Parameters Committee of the American College of Gastroenterology
    • Blei AT, Cordoba J, Practice Parameters Committee of the American College of Gastroenterology. Hepatic encephalopathy. Am J Gastroenterol 2001;96:1968-1976
    • (2001) Am J Gastroenterol , vol.96 , pp. 1968-1976
    • Blei, A.T.1    Cordoba, J.2
  • 6
    • 1642491776 scopus 로고    scopus 로고
    • Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis
    • Shawcross DL, Davies NA, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 2004; 40:247-254
    • (2004) J Hepatol , vol.40 , pp. 247-254
    • Shawcross, D.L.1    Davies, N.A.2    Williams, R.3    Jalan, R.4
  • 7
    • 2342487336 scopus 로고    scopus 로고
    • Non-absorbable disaccharides for hepatic encephalopathy: Systematic review of randomised trials
    • Als-Nielsen B, Gludd LL, Gluud C. Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials. BMJ 2004;328:1046-1051
    • (2004) BMJ , vol.328 , pp. 1046-1051
    • Als-Nielsen, B.1    Gludd, L.L.2    Gluud, C.3
  • 8
    • 77950246404 scopus 로고    scopus 로고
    • Rifaximin treatment in hepatic encephalopathy
    • Bass NM, Mullen KD, Sanyal A, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med 2010;362:1071-1081
    • (2010) N Engl J Med , vol.362 , pp. 1071-1081
    • Bass, N.M.1    Mullen, K.D.2    Sanyal, A.3
  • 9
    • 2342580955 scopus 로고    scopus 로고
    • Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with liver cirrhosis
    • Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with liver cirrhosis. Hepatology 2004;39:1441-1449
    • (2004) Hepatology , vol.39 , pp. 1441-1449
    • Liu, Q.1    Duan, Z.P.2    Ha, D.K.3    Bengmark, S.4    Kurtovic, J.5    Riordan, S.M.6
  • 10
    • 75749125436 scopus 로고    scopus 로고
    • Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy
    • Malaguarnera M, Gargante MP, Malaguarnera G, et al. Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy. Eur J Gastroenterol Hepatol 2010;22:199-206.
    • (2010) Eur J Gastroenterol Hepatol , vol.22 , pp. 199-206
    • Malaguarnera, M.1    Gargante, M.P.2    Malaguarnera, G.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.